Search | IOVS | ARVO Journals

Showing 1 – 20 of 26

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2018

Analyses of data in Japanese Retina and Vitreous Society registry on eyes with rhegmatogenous retinal detachments

Takayuki Baba; Taiji Sakamoto; Ryo Kawasaki; Akito Hirakata; Shuichi Yamamoto; Koichi Nishitsuka; Takashi Koto; Keita Yamakiri; Kazuaki Kadonosono; Masahito Ohji; Hidetoshi Yamashita; Yuichiro Ogura

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1834. doi:

ARVO Annual Meeting Abstract June 2017

Abicipar pegol in neovascular age-related macular degeneration (nAMD): comparability between Japanese and non-Japanese patients, and treatment effects on polypoidal choroidal vasculopathy (PCV) and non-PCV patients

Derek Kunimoto; Masahito Ohji; Raj K Maturi; Tetsuju Sekiryu; Ying Wang; Grace Pan; Xiao-Yan Li; Susan Schneider

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1959. doi:

ARVO Annual Meeting Abstract June 2017

Comparison between wide angle OCT angiography and ultra-wide field fluorescein angiography on the detection of non-perfusion area

Osamu Sawada; Yusuke Ichiyama; Yuka Ito; Masashi Kakinoki; Tomoko Sawada; Yoshitsugu Saishin; Masahito Ohji

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1700. doi:

ARVO Annual Meeting Abstract June 2017

Topical bromfenac as an adjunctive treatment with intravitreal ranibizumab for macular edema associated with branch retinal vein occlusion

Yoshitsugu Saishin; Yuka Ito; Masashi Kakinoki; Masahito Ohji

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3653. doi:

ARVO Annual Meeting Abstract September 2016

Aqueous vascular endothelial growth factor after bimonthly intravitreal injection of ranibizumab or aflibercept in patients with diabetic macular edema

Osamu Sawada; Yusuke Ichiyama; Yuka Ito; Masato Fujikawa; Masashi Kakinoki; Tomoko Sawada; Yoshitsugu Saishin; Masahito Ohji

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi:

Physiology and Pharmacology October 2015

Ranibizumab and Aflibercept: Intraocular Pharmacokinetics and Their Effects on Aqueous VEGF Level in Vitrectomized and Nonvitrectomized Macaque Eyes

PDF

Yuichi Niwa; Masashi Kakinoki; Tomoko Sawada; Xiying Wang; Masahito Ohji
TAGS: vascular endothelial growth factor a, macaca, aqueous humor, eye, pharmacokinetics, ranibizumab, aflibercept
Invest. Ophthalmol. Vis. Sci.. 2015; 56(11):6501-6505. doi: 10.1167/iovs.15-17279

ARVO Annual Meeting Abstract June 2015

Pneumatic Displacement In Combination With Anti-VEGF Therapy For Subretinal Hemorrhage Secondary To Polypoidal Choroidal Vasculopathy

Masato Fujikawa; Osamu Sawada; Tomoko Sawada; Yoshitsugu Saishin; Hajime Kawamura; Masahito Ohji

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2844. doi:

ARVO Annual Meeting Abstract June 2015

Aqueous vascular endothelial growth factor before and after intravitreal injection of bevacizumab or ranibizumab in patients with diabetic macular edema

Osamu Sawada; Masato Fujikawa; Yuka Ito; Tomoko Sawada; Masahito Ohji

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1753. doi:

Glaucoma October 2014

Evaluation of Acquired Color Vision Deficiency in Glaucoma Using the Rabin Cone Contrast Test

PDF

Yuichi Niwa; Sanae Muraki; Fumiyuki Naito; Takayuki Minamikawa; Masahito Ohji
TAGS: glaucoma, color vision defect, retinal cone, glaucoma screening
Invest. Ophthalmol. Vis. Sci.. 2014; 55(10):6686-6690. doi: 10.1167/iovs.14-14079

ARVO Annual Meeting Abstract April 2014

Serum and aqueous vascular endothelial growth factor concentration of patients with age-related macular degeneration after intravitreal injection of aflibercept

Xiying Wang; Tomoko Sawada; Osamu Sawada; Yoshitsugu Saishin; Masahito Ohji

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1956. doi:

ARVO Annual Meeting Abstract April 2014

Characterization and evaluation of sugar-chain modified liposome encapsulated with human immunoglobulin for intravitreal administration

Maki Iwasa; Yoshitsugu Saishin; Xiying Wang; Masahito Ohji

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):465. doi:

ARVO Annual Meeting Abstract April 2014

Bimonthly injections of ranibizumab for age-related macular degeneration

Tomoko Sawada; Xiying Wang; Osamu Sawada; Yoshitsugu Saishin; Masahito Ohji

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3944. doi:

ARVO Annual Meeting Abstract April 2014

Photoreceptor outer segment length and outer foveal thickness as predictive factors associated with visual outcome after vitrectomy for vitreomacular traction syndrome

Yusuke Ichiyama; Hajime Kawamura; Masato Fujikawa; Osamu Sawada; Yoshitsugu Saishin; Masahito Ohji

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):297. doi:

ARVO Annual Meeting Abstract April 2014

Changes of retinal thickness after vitrectomy for epiretinal membrane with and without internal limiting membrane peeling

Shumpei Obata; Keisuke Iwasaki; Masato Fujikawa; Masashi Kakinoki; Osamu Sawada; Yoshitsugu Saishin; Hajime Kawamura; Masahito Ohji

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1151. doi:

ARVO Annual Meeting Abstract June 2013

Aqueous Vascular Endothelial Growth Factor and Ranibizumab Concentrations after Monthly and Bimonthly Intravitreal Injections of Ranibizumab for Age-Related Macular Degeneration

Xiying Wang; Tomoko Sawada; Masashi Kakinoki; Taichiro Miyake; Hajime Kawamura; Yoshitsugu Saishin; Ping Liu; Masahito Ohji

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3169. doi:

ARVO Annual Meeting Abstract June 2013

A new 25G back flush needle

Shumpei Obata; Kenji Someya; Masashi Kakinoki; Masahito Ohji

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3330. doi:

ARVO Annual Meeting Abstract June 2013

The efficacy of bimonthly injection of ranibizumab for age-related macular degeneration for six months

Tomoko Sawada; Masashi Kakinoki; Xiying Wang; Hajime Kawamura; Yoshitsugu Saishin; Masahito Ohji

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3804. doi:

ARVO Annual Meeting Abstract June 2013

Signal intensity measurement of magnetic resonance imaging for extraocular muscles inflammation in thyroid-associated ophthalmopathy before and after methylprednisolone pulse therapy

Tomoaki Higashiyama; Yasuhiro Nishida; Yusuke Ichiyama; Sanae Muraki; Masahito Ohji

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):5900. doi:

ARVO Annual Meeting Abstract June 2013

A lack of delayed intraocular pressure elevation after intravitreal injections of ranibizumab for age-related macular degeneration

Yusuke Ichiyama; Tomoko Sawada; Masashi Kakinoki; Osamu Sawada; Yoshitsugu Saishin; Hajime Kawamura; Masahito Ohji

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):6300. doi:

Retina August 2012

Effect of Vitrectomy on Aqueous VEGF Concentration and Pharmacokinetics of Bevacizumab in Macaque Monkeys

PDF

Masashi Kakinoki; Osamu Sawada; Tomoko Sawada; Yoshitsugu Saishin; Hajime Kawamura; Masahito Ohji
TAGS: vascular endothelial growth factor a, cercopithecidae, macaca, vitrectomy, aqueous humor, eye, pharmacokinetics, bevacizumab, mass or substance concentration per volume
Invest. Ophthalmol. Vis. Sci.. 2012; 53(9):5877-5880. doi: 10.1167/iovs.12-10164

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Analyses of data in Japanese Retina and Vitreous Society registry on eyes with rhegmatogenous retinal detachments

Abicipar pegol in neovascular age-related macular degeneration (nAMD): comparability between Japanese and non-Japanese patients, and treatment effects on polypoidal choroidal vasculopathy (PCV) and non-PCV patients

Comparison between wide angle OCT angiography and ultra-wide field fluorescein angiography on the detection of non-perfusion area

Topical bromfenac as an adjunctive treatment with intravitreal ranibizumab for macular edema associated with branch retinal vein occlusion

Aqueous vascular endothelial growth factor after bimonthly intravitreal injection of ranibizumab or aflibercept in patients with diabetic macular edema

Ranibizumab and Aflibercept: Intraocular Pharmacokinetics and Their Effects on Aqueous VEGF Level in Vitrectomized and Nonvitrectomized Macaque Eyes

Pneumatic Displacement In Combination With Anti-VEGF Therapy For Subretinal Hemorrhage Secondary To Polypoidal Choroidal Vasculopathy

Aqueous vascular endothelial growth factor before and after intravitreal injection of bevacizumab or ranibizumab in patients with diabetic macular edema

Evaluation of Acquired Color Vision Deficiency in Glaucoma Using the Rabin Cone Contrast Test

Serum and aqueous vascular endothelial growth factor concentration of patients with age-related macular degeneration after intravitreal injection of aflibercept

Characterization and evaluation of sugar-chain modified liposome encapsulated with human immunoglobulin for intravitreal administration

Bimonthly injections of ranibizumab for age-related macular degeneration

Photoreceptor outer segment length and outer foveal thickness as predictive factors associated with visual outcome after vitrectomy for vitreomacular traction syndrome

Changes of retinal thickness after vitrectomy for epiretinal membrane with and without internal limiting membrane peeling

Aqueous Vascular Endothelial Growth Factor and Ranibizumab Concentrations after Monthly and Bimonthly Intravitreal Injections of Ranibizumab for Age-Related Macular Degeneration

A new 25G back flush needle

The efficacy of bimonthly injection of ranibizumab for age-related macular degeneration for six months

Signal intensity measurement of magnetic resonance imaging for extraocular muscles inflammation in thyroid-associated ophthalmopathy before and after methylprednisolone pulse therapy

A lack of delayed intraocular pressure elevation after intravitreal injections of ranibizumab for age-related macular degeneration

Effect of Vitrectomy on Aqueous VEGF Concentration and Pharmacokinetics of Bevacizumab in Macaque Monkeys

To View More...

You must be signed into an individual account to use this feature.